Insight

Turning Biospecimens into Strategic Research Assets with Labmatrix®

How a multinational pharmaceutical company and IQVIA Laboratories digitized biobanking to accelerate scientific discovery

Turning Biospecimens into Strategic Research Assets with Labmatrix®

Home / Insights / Turning Biospecimens into Strategic Research Assets with Labmatrix®

Learn more about how a multinational pharmaceutical company partnered with IQVIA Laboratories to digitize biobanking using Labmatrix<sup>®</sup>

Complete the form below to access this case study.

Related Insights

AI at the Core: A Vision for the Future of Labmatrix

Driving Excellence in Specimen Lifecycle Management: Change Management and Metrics

Accelerating Quality Control: Leveraging Study QC Dashboards to Save Time

Mobile Solutions for Real-Time Visibility into Clinical Trial Samples

AI and Machine Learning Initiatives in Labmatrix

Integration with external systems

Mastering Labmatrix Extensions: Workshop on UI Override Functionality

Enhancing Data Ingestion: Workshop on Pattern Matching Functionality in Labmatrix

Transforming Biomarker Data Management: Implementing Labmatrix at Children’s Cancer Institute

Empowering Innovation: Leveraging Low-Code/No-Code Capabilities in Labmatrix

© 2026 IQVIA. All rights reserved.

Terms of use Privacy Policy Your Privacy Choices